Paul Clancy
2017
In 2017, Paul Clancy earned a total compensation of $11.4M as Executive Vice President and Chief Financial Officer at Alexion Pharmaceuticals.
Compensation breakdown
| Bonus | $500,000 |
|---|---|
| Non-Equity Incentive Plan | $473,620 |
| Option Awards | $1,220,082 |
| Salary | $415,385 |
| Stock Awards | $8,799,954 |
| Other | $2,262 |
| Total | $11,411,303 |
Clancy received $8.8M in stock awards, accounting for 77% of the total pay in 2017.
Clancy also received $500K in bonus, $473.6K in non-equity incentive plan, $1.2M in option awards, $415.4K in salary and $2.3K in other compensation.
Rankings
In 2017, Paul Clancy's compensation ranked 498th out of 14,666 executives tracked by ExecPay. In other words, Clancy earned more than 96.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 498 out of 14,666 | 97th |
Division Manufacturing | 158 out of 5,772 | 97th |
Major group Chemicals And Allied Products | 38 out of 2,075 | 98th |
Industry group Drugs | 27 out of 1,731 | 98th |
Industry Pharmaceutical Preparations | 24 out of 1,333 | 98th |
Source: SEC filing on March 26, 2019.
Clancy's colleagues
We found five more compensation records of executives who worked with Paul Clancy at Alexion Pharmaceuticals in 2017.
2017
Ludwig Hantson
Alexion Pharmaceuticals
Chief Executive Officer
2017
Julie O'Neill
Alexion Pharmaceuticals
Former Executive Vice President of Global Operations
2017
Brian Goff
Alexion Pharmaceuticals
Executive Vice President and Chief Commercial Officer
2017
John Orloff
Alexion Pharmaceuticals
Executive Vice President, Head of Research & Development
2017
Anne-Marie Law
Alexion Pharmaceuticals